Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Transitional Cell × belinostat × Clear all

Sponsor

Conditions

Fallopian Tube Neoplasms 3 Ovarian Neoplasms 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Leukemia, Myeloid, Acute 2 Carcinoma, Ovarian Epithelial 2 Urinary Bladder Neoplasms 1 Thymoma 1 Solitary Fibrous Tumor, Pleural 1 Sarcoma 1 Neoplasms, Unknown Primary 1 Neoplasms 1 Myelodysplastic Syndromes 1 Mesothelioma, Malignant 1 Mediastinal Neoplasms 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Liver Diseases 1 Leukemia-Lymphoma, Adult T-Cell 1 Congenital Abnormalities 1 Carcinoma, Hepatocellular 1 Burkitt Lymphoma 1 Brenner Tumor 1

Interventions

pembrolizumab 21 atezolizumab 12 Gemcitabine 12 Nivolumab 10 Cisplatin 10 Docetaxel 8 Carboplatin 8 Mitomycin 5 avelumab 4 Ipilimumab 4 pemigatinib 3 epacadostat 3 Paclitaxel 3 Bevacizumab 3 vofatamab 2 lenvatinib 2 enfortumab vedotin 2 cabozantinib 2 cabazitaxel 2 bempegaldesleukin 2 Standard of Care 2 Rogaratinib 2 Ramucirumab 2 Platinum 2 Pemetrexed 2 Everolimus 2 Biopsy 2 B701 protein, Human herpesvirus 6 2 Albumin-Bound Paclitaxel 2 1,2-diaminocyclohexaneplatinum II citrate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡